Search by Drug Name or NDC

NDC 68788-8153-07 Tadalafil 20 mg/1 Details

Tadalafil 20 mg/1

Tadalafil is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Preferred Pharmaceuticals Inc.. The primary component is TADALAFIL.

MedlinePlus Drug Summary

Tadalafil (Cialis) is used to treat erectile dysfunction (ED, impotence; inability to get or keep an erection), and the symptoms of benign prostatic hyperplasia (BPH; an enlarged prostate) which include difficulty urinating (hesitation, dribbling, weak stream, and incomplete bladder emptying), painful urination, and urinary frequency and urgency in adult men. Tadalafil (Adcirca) is used to improve the ability to exercise in people with pulmonary arterial hypertension (PAH; high blood pressure in the vessels carrying blood to the lungs, causing shortness of breath, dizziness, and tiredness). Tadalafil is in a class of medications called phosphodiesterase (PDE) inhibitors. It works to treat erectile dysfunction by increasing blood flow to the penis during sexual stimulation. This increased blood flow can cause an erection. Tadalafil treats PAH by relaxing the blood vessels in the lungs to allow blood to flow more easily. If you are taking tadalafil to treat erectile dysfunction, you should know that it does not cure erectile dysfunction or increase sexual desire. Tadalafil does not prevent pregnancy or the spread of sexually transmitted diseases such as human immunodeficiency virus (HIV).

Related Packages: 68788-8153-07
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Tadalafil

Product Information

NDC	68788-8153
Product ID	68788-8153_e5b99a0c-aab1-458e-ab34-406bc9294125
Associated GPIs	40304080000320
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Tadalafil
Proprietary Name Suffix	n/a
Non-Proprietary Name	Tadalafil
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	20
Active Ingredient Units	mg/1
Substance Name	TADALAFIL
Labeler Name	Preferred Pharmaceuticals Inc.
Pharmaceutical Class	Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA209167
Listing Certified Through	2024-12-31

Package

NDC 68788-8153-07 (68788815307)

Pricing Information	N/A
NDC Package Code	68788-8153-7
Billing NDC	68788815307
Package	7 TABLET, FILM COATED in 1 BOTTLE (68788-8153-7)
Marketing Start Date	2022-03-14
NDC Exclude Flag	N